Abstract MP48: Null Causal Associations between Circulating Caffeine Levels and its Metabolites with Cardiac Function and Heart Failure

Introduction: Observational studies have shown that coffee consumption relates to a decreased risk of heart failure (HF). Our recent findings indicate that caffeine metabolism, not caffeine itself, relates to the onset of HF. The causal effect of circulating caffeine levels on HF and cardiac function is largely inconclusive. Hypothesis: We hypothesize that circulating caffeine level is not causally associated with cardiac function and HF. Methods: We extracted the summary results from genome-wide association (GWAS) studies of plasma caffeine, HF, and 15 cardiac structure and function measures for left atrium, left ventricle, and right ventricle from public databases. Genetic instruments of caffeine were selected if the variants were associated with caffeine at p<5×10 -8 . After clumping at r<0.001, two independent lead variants on gene CYP1A2 , rs2472297, and AHR , rs4410790, were included in the analysis. Using the two-sample Mendelian Randomization (MR) approach, we examined the associations between caffeine level, cardiac function measurements, and HF on each selected variant, and pooled estimates were generated using the inverse-variance weighted method. Results: The summary of caffeine, cardiac function, and HF was from GWAS of European descent, consisting of 9,876 participants from six cohorts, up to 29,506 participants from UK Biobank, and 47,309 cases and 93,014 controls from the Heart Failure Molecular Epidemiology for Therapeutic Targets study, respectively. CYP1A2 and AHR were not causally associated with HF individually or jointly (Odds Ratio meta =1.001, 95% CI = 0.999, 1.004). Both genes also yield insignificant results between caffeine levels and measures of the left ventricle, left atrium, and right ventricle, key parameters underlying HF ( Figure ). Conclusion: We observed no causal association between circulating caffeine and the risk of HF, suggesting health-beneficial effects of coffee consumption may relate to the improved molecular pathways instead of circulating caffeine levels.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-03-11
DOI
https://doi.org/10.1161/cir.151.suppl_1.mp48
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract MP48: Null Causal Associations between Circulating Caffeine Levels and its Metabolites with Cardiac Function and Heart Failure

William B. Perkison, Bing Yu, Guning Liu
Circulation
Diet and metabolism studies
article

Abstract MP48: Null Causal Associations between Circulating Caffeine Levels and its Metabolites with Cardiac Function and Heart Failure

William B. Perkison, Bing Yu, Guning Liu
article en

Abstract

Introduction: Observational studies have shown that coffee consumption relates to a decreased risk of heart failure (HF). Our recent findings indicate that caffeine metabolism, not caffeine itself, relates to the onset of HF. The causal effect of circulating caffeine levels on HF and cardiac function is largely inconclusive. Hypothesis: We hypothesize that circulating caffeine level is not causally associated with cardiac function and HF. Methods: We extracted the summary results from genome-wide association (GWAS) studies of plasma caffeine, HF, and 15 cardiac structure and function measures for left atrium, left ventricle, and right ventricle from public databases. Genetic instruments of caffeine were selected if the variants were associated with caffeine at p<5×10 -8 . After clumping at r<0.001, two independent lead variants on gene CYP1A2 , rs2472297, and AHR , rs4410790, were included in the analysis. Using the two-sample Mendelian Randomization (MR) approach, we examined the associations between caffeine level, cardiac function measurements, and HF on each selected variant, and pooled estimates were generated using the inverse-variance weighted method. Results: The summary of caffeine, cardiac function, and HF was from GWAS of European descent, consisting of 9,876 participants from six cohorts, up to 29,506 participants from UK Biobank, and 47,309 cases and 93,014 controls from the Heart Failure Molecular Epidemiology for Therapeutic Targets study, respectively. CYP1A2 and AHR were not causally associated with HF individually or jointly (Odds Ratio meta =1.001, 95% CI = 0.999, 1.004). Both genes also yield insignificant results between caffeine levels and measures of the left ventricle, left atrium, and right ventricle, key parameters underlying HF ( Figure ). Conclusion: We observed no causal association between circulating caffeine and the risk of HF, suggesting health-beneficial effects of coffee consumption may relate to the improved molecular pathways instead of circulating caffeine levels.

CirculationVol. 151(Suppl_1)
The University of Texas Health Science Center at Houston (US)
Openalex Percentile: Top 90%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.